LY2189265

DRUG19 trials

Conditions

Diabetes Mellitus Type 2Diabetes Mellitus, Type 2Diabetes Mellitus, Type IIHealthy VolunteersType 2 DiabetesType 2 Diabetes Mellitus

Phase 1

A Study to Evaluate the Effect of LY2189265 on the Speed at Which Food and Drink Leaves the Stomach in Patients With Type 2 Diabetes Mellitus

CompletedNCT01215968

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2010-09-30End: 2011-07-31Updated: 2014-10-07

LY2189265 and Atorvastatin Interaction Study

CompletedNCT01250834

Eli Lilly and CompanyHealthy Volunteers

Start: 2010-12-31End: 2011-03-31Updated: 2014-10-08

A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) Impairment

CompletedNCT01253304

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2010-11-30End: 2011-11-30Updated: 2014-10-07

Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose

CompletedNCT01300260

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2011-02-28End: 2011-08-31Updated: 2014-10-07

A Study to Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunteers.

CompletedNCT01301092

Eli Lilly and CompanyDiabetes Mellitus, Type II

Start: 2011-02-28End: 2011-08-31Updated: 2014-10-07

A Study of the Effect of LY2189265 on Two Blood Pressure Drugs

CompletedNCT01324388

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2011-03-31End: 2011-08-31Updated: 2014-10-08

A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes

CompletedNCT01408888

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2011-08-31End: 2012-04-30Updated: 2014-10-07

Phase 2

A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus

CompletedNCT00630825

Eli Lilly and CompanyDiabetes Mellitus Type 2

Start: 2008-04-30End: 2009-01-31Updated: 2014-12-10

A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin

CompletedNCT00734474

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2008-08-31End: 2012-07-31Updated: 2015-04-20

A Study of LY2189265 in Japanese Patients With Type 2 Diabetes

CompletedNCT01001104

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2009-10-31End: 2010-12-31Updated: 2015-09-28

A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes

CompletedNCT01149421

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2010-06-30End: 2012-01-31Updated: 2015-02-02

Phase 3

A Study in Participants With Type 2 Diabetes Mellitus

CompletedNCT01064687

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2010-02-28End: 2012-05-31Updated: 2015-01-26

A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)

CompletedNCT01075282

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2010-02-28End: 2012-11-30Updated: 2015-01-16

A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3)

CompletedNCT01126580

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2010-05-31End: 2012-06-30Updated: 2015-01-16

A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)

CompletedNCT01191268

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2010-11-30End: 2012-09-30Updated: 2014-10-08

A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

CompletedNCT01468181

Eli Lilly and CompanyType 2 Diabetes Mellitus

Start: 2011-11-30End: 2013-12-31Updated: 2015-01-29

A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

CompletedNCT01558271

Eli Lilly and CompanyType 2 Diabetes Mellitus

Start: 2012-03-31End: 2014-05-31Updated: 2015-05-22

A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus

CompletedNCT01584232

Eli Lilly and CompanyType 2 Diabetes Mellitus

Start: 2012-04-30End: 2013-07-31Updated: 2014-10-20

A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes

CompletedNCT01624259

Eli Lilly and CompanyType 2 Diabetes

Start: 2012-06-30End: 2013-11-30Updated: 2014-10-09

JAMA Network Open2023-04-1119 citations

Weight-dependent and weight-independent effects of dulaglutide on blood pressure in patients with type 2 diabetes.

2023-03-0912 citations

No calcitonin change in a person taking dulaglutide diagnosed with pre-existing medullary thyroid cancer.

2018-03-018 citations

The cost-effectiveness of dulaglutide versus insulin glargine for the treatment of type 2 diabetes mellitus in Japan.

2018-02-0710 citations

Subgroup Analysis Stratified by Baseline Pancreatic β-cell Function in a Japanese Study of Dulaglutide in Patients with Type 2 Diabetes.

2017-12-203 citations

No Dose Adjustment is Recommended for Digoxin, Warfarin, Atorvastatin or a Combination Oral Contraceptive When Coadministered with Dulaglutide.

2017-11-0118 citations

Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies.

2017-06-1210 citations

Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study.

2015-05-01173 citations

Dulaglutide Reduces HbA1c More Than Glargine When Used in Combination with Prandial Insulin

MD Conference Express2014-11-01

Dulaglutide Noninferior to Liraglutide for Glycemic Control in Patients with T2DM

MD Conference Express2014-11-01

Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial.

2014-07-10371 citations

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01

Once-Weekly Dulaglutide Produces Superior Glycemic Control Compared with Metformin

MD Conference Express2013-11-01

LY2189265

Sponsors

Conditions

Phase 1

Phase 2

Phase 3

Related Papers